• 1
    Thrusfield MV, Aiken CG, Darke PG. Observations on breed and sex in relation to canine heart valve incompetence. J Small Anim Pract 1985;26:709717.
  • 2
    Kvart C, Häggstrom J. Acquired valvular heart disease. In: EttingerSJ, FeldmanEC, eds. Textbook of Veterinary Internal Medicine, 6th ed. Philadelphia, PA: WB Saunders; 2005:10221039.
  • 3
    International Small Animal Cardiac Health Council. Appendix A: Recommendations for diagnosis of heart disease and treatment of heart failure in small animals. In: FoxPR, SissonD, MoïseNS., eds. Textbook of Canine and Feline Cardiology, 2nd ed. Philadelphia, PA: WB Saunders; 1999:883901.
  • 4
    Kvart C, Häggström J, Pedersen HD, et al. Efficacy of enalapril for prevention of congestive heart failure in dogs with myxomatous valve disease and asymptomatic mitral regurgitation. J Vet Intern Med 2002;16:8088.
  • 5
    Atkins CE, Keene BW, Brown WA, et al. Results of the veterinary enalapril trial to prove reduction in onset of heart failure in dogs chronically treated with enalapril alone for compensated, naturally occurring mitral valve insufficiency. J Am Vet Med Assoc 2007;231:10611069.
  • 6
    Pouchelon JL, Jamet N, Gouni V, et al. Effect of benazepril on survival and cardiac events in dogs with asymptomatic mitral valve disease: A retrospective study of 141 cases. J Vet Intern Med 2008;22:905914.
  • 7
    Borgarelli M, Savarino P, Crosara S, et al. Survival characteristics and prognostic variables of dogs with mitral regurgitation attributable to myxomatous valve disease. J Vet Intern Med 2008;22:120128.
  • 8
    Pouchelon JL, Martignoni L, King JN, et al. The BENCH Study Group. The effect of benazepril on survival times and clinical signs of dogs with congestive heart failure: Results of a multicenter, prospective, randomised, double-blinded, placebo-controlled, long-term clinical trial. J Vet Cardiol 1999;1:718.
  • 9
    Ettinger SJ, Benitz AM, Ericsson GF, et al. Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. The Long-Term Investigation of Veterinary Enalapril (LIVE) Study Group. J Am Vet Med Assoc 1998;213:15731577.
  • 10
    Häggström J, Boswood A, O'Grady M, et al. Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: The QUEST study. J Vet Intern Med 2008;22:11241135.
  • 11
    Enriquez-Sarano M, Avierinos J-F, Messika-Zeitoon D, et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med 2005;352:875883.
  • 12
    Gouni V, Serres FJ, Pouchelon JL, et al. Quantification of mitral valve regurgitation in dogs with degenerative mitral valve disease by use of the proximal isovelocity surface area method. J Am Vet Med Assoc 2007;231:399406.
  • 13
    Serres F, Chetboul V, Gouni V, et al. Diagnostic value of echo-Doppler and tissue Doppler imaging in dogs with pulmonary arterial hypertension. J Vet Intern Med 2007;21:12801289.
  • 14
    Serres F, Chetboul V, Tissier R, et al. Chordae tendinae rupture in dogs with degenerative mitral valve disease: Prevalence, survival and prognostic factors (114 cases, 2001–2006). J Vet Intern Med 2007;21:258264.
  • 15
    Nicolle AP, Chetboul V, Allerheiligen T, et al. Azotemia and glomerular filtration rate in dogs with chronic valvular disease. J Vet Intern Med 2007;21:943949.
  • 16
    Schöber KA. Biochemical markers of cardiovascular disease. In: EttingerSJ, FeldmanEC, eds. Textbook of Veterinary Internal Medicine, 6th ed. Philadelphia, PA: WB Saunders; 2005:940948.
  • 17
    Abassi Z, Karram T, Ellaham S, et al. Implications of the natriuretic peptide system in the pathogenesis of heart failure: Diagnostic and therapeutic. Pharmacol Ther 2004;102:223241.
  • 18
    Fine DM, Declue AE, Reinero CR. Evaluation of circulating amino terminal-pro-B-type natriuretic peptide concentration in dogs with respiratory distress attributable to congestive heart failure or primary pulmonary disease. J Am Vet Med Assoc 2008;232:16741679.
  • 19
    Boswood A, Dukes-McEwan J, Loureiro J, et al. The diagnostic accuracy of different natriuretic peptides in the investigation of canine cardiac disease. J Small Anim Pract 2008;49:2632.
  • 20
    Oyama MA, Fox PR, Rush JE. Clinical utility of serum N-terminal pro-B-type natriuretic peptide concentration for identifying cardiac disease in dogs and assessing disease severity. J Am Vet Med Assoc 2008;232:14961503.
  • 21
    Tarnow I, Olsen LH, Kvart C, et al. Predictive value of natriuretic peptides in dogs with mitral valve disease. Vet J 2009;180:195201.
  • 22
    Chetboul V, Tessier-Vetzel D, Escriou C, et al. Diagnostic potential of natriuretic peptides in the occult phase of golden retriever muscular dystrophy cardiomyopathy. J Vet Intern Med 2004;18:845850.
  • 23
    Chetboul V, Athanassiadis N, Concordet D, et al. Observer-dependent variability of quantitative clinical endpoint: Example of canine echocardiography. J Vet Pharmacol Ther 2004;27:4956.
  • 24
    Chetboul V, Carlos Sampedrano C, Concordet D, et al. Use of quantitative two-dimensional color tissue Doppler imaging for assessment of left ventricular radial and longitudinal myocardial velocities in dogs. Am J Vet Res 2005;66:953961.
  • 25
    Sahn DJ, DeMaria A, Kisslo J, et al. Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements. Circulation 1978;58:10721083.
  • 26
    Serres F, Chetboul V, Tissier R, et al. Comparison of 3 ultrasound methods for quantifying left ventricular systolic function: Correlation with disease severity and prognostic value in dogs with mitral valve disease. J Vet Intern Med 2008;22:56677.
  • 27
    BonaguraJD, ed. Appendix in Kirk's Current Veterinary Therapy, Small Animal Practice, Vol. XIII. Philadelphia, PA: WB Saunders, 2000.
  • 28
    Serres FJ, Chetboul V, Tissier R, et al. Doppler echocardiography-derived evidence of pulmonary arterial hypertension in dogs with degenerative mitral valve disease: 86 cases (2001–2005). J Am Vet Med Assoc 2006;229:17721778.
  • 29
    Serfass P, Chetboul V, Carlos Sampedrano C, et al. Retrospective study of 942 small sized-dogs: Prevalence of left apical systolic heart murmur and left-sided heart failure, critical effects of breed, and sex. J Vet Cardiol 2006;8:18.
  • 30
    Chetboul V, Tissier R, Villaret F, et al. Epidemiological, clinical, echo-Doppler characteristics of mitral valve endocardiosis in Cavalier King Charles in France: A retrospective study of 451 cases (1995 to 2003). Can Vet J 2004;45:10121015.
  • 31
    Mueller T, Gegenhuber A, Poelz W, et al. Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure. Heart 2005;91:606612.
  • 32
    Wang TJ, Larson MG, Levy D, et al. Plasma natriuretic levels and the risk of cardiovascular events and death. N Engl J Med 2004;350:655663.
  • 33
    Bayes-Genis A, Pascual-Figal D, Fabregat J, et al. Serial NT-proBNP monitoring and outcomes in outpatients with decompensation of heart failure. Int J Cardiol 2007;120:338343.